FDA 2016: New FDA Commissioner, PDUFA Reauthorization Process, & Biomarkers – Workshop at Annual Biotech Showcase to Feature Catalyst

What are the important regulatory issues for investors and biopharma companies in 2016? Join us during the 8th annual Biotech Showcase conference on Jan. 13, as Catalyst offers insights on key regulatory issues for stakeholders in the coming year, including a new FDA Commissioner, biomarker qualification and PDUFA reauthorization. Catalyst President Nancy Bradish Myers will join fellow panelist David M. Fox, Partner, Hogan Lovells and moderator Joseph V. Gulfo, Director, Rothman Institute of Innovation and Entrepreneurship, Fairleigh Dickinson University.